J
Jie Li
Researcher at Wuhan University
Publications - 277
Citations - 9800
Jie Li is an academic researcher from Wuhan University. The author has contributed to research in topics: Hyperspectral imaging & Image resolution. The author has an hindex of 37, co-authored 248 publications receiving 7109 citations. Previous affiliations of Jie Li include Scripps Institution of Oceanography & Sichuan University.
Papers
More filters
Journal ArticleDOI
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
W. Marston Linehan,Paul T. Spellman,Christopher J. Ricketts,Chad J. Creighton,Suzanne S. Fei,Caleb F. Davis,David A. Wheeler,Bradley A. Murray,Laura S. Schmidt,Cathy D. Vocke,Myron Peto,Abu Amar M. Al Mamun,Eve Shinbrot,Anurag Sethi,Samira A. Brooks,W. Kimryn Rathmell,Angela N. Brooks,Katherine A. Hoadley,A. Gordon Robertson,Denise Brooks,Reanne Bowlby,Sara Sadeghi,Hui Shen,Daniel J. Weisenberger,Moiz S. Bootwalla,Stephen B. Baylin,Peter W. Laird,Andrew D. Cherniack,Gordon Saksena,Scott M. Haake,Jun Li,Han Liang,Yiling Lu,Gordon B. Mills,Rehan Akbani,Mark D.M. Leiserson,Benjamin J. Raphael,Pavana Anur,Donald P. Bottaro,Laurence Albiges,Nandita Barnabas,Toni K. Choueiri,Bogdan Czerniak,Andrew K. Godwin,A. Ari Hakimi,Thai H. Ho,James J. Hsieh,Michael M. Ittmann,William Y. Kim,Bhavani Krishnan,Maria Merino,Kenna R. Mills Shaw,Victor E. Reuter,Ed Reznik,Carl Simon Shelley,Brian Shuch,Sabina Signoretti,Ramaprasad Srinivasan,Pheroze Tamboli,George Thomas,Satish K. Tickoo,Kenneth Burnett,Daniel Crain,Johanna Gardner,Kevin Lau,David Mallery,Scott Morris,Joseph Paulauskis,Robert Penny,Candace Shelton,W. Troy Shelton,Mark E. Sherman,Eric M. Thompson,Peggy Yena,Melissa T. Avedon,Jay Bowen,Julie M. Gastier-Foster,Mark Gerken,Kristen M. Leraas,Tara M. Lichtenberg,Nilsa C. Ramirez,Tracie Santos,Lisa Wise,Erik Zmuda,John A. Demchok,Ina Felau,Carolyn M. Hutter,Margi Sheth,Heidi J. Sofia,Roy Tarnuzzer,Zhining Wang,Liming Yang,Jean C. Zenklusen,Jiashan Zhang,Brenda Ayala,Julien Baboud,Sudha Chudamani,Jia Liu,Laxmi Lolla,Rashi Naresh,Todd Pihl,Qiang Sun,Yunhu Wan,Ye Wu,Adrian Ally,Miruna Balasundaram,Saianand Balu,Rameen Beroukhim,Tom Bodenheimer,Christian J. Buhay,Yaron S.N. Butterfield,Rebecca Carlsen,Scott L. Carter,Hsu Chao,Eric Chuah,Amanda Clarke,Kyle R. Covington,Mahmoud Dahdouli,Ninad Dewal,Noreen Dhalla,Harsha Doddapaneni,Jennifer Drummond,Stacey Gabriel,Richard A. Gibbs,Ranabir Guin,Walker Hale,Alicia Hawes,D. Neil Hayes,Robert A. Holt,Alan P. Hoyle,Stuart R. Jefferys,Steven J.M. Jones,Corbin D. Jones,Divya Kalra,Christie Kovar,Lora Lewis,Jie Li,Yussanne Ma,Marco A. Marra,Michael Mayo,Shaowu Meng,Matthew Meyerson,Piotr A. Mieczkowski,Richard A. Moore,Donna Morton,Lisle E. Mose,Andrew J. Mungall,Donna M. Muzny,Joel S. Parker,Charles M. Perou,Jeffrey Roach,Jacqueline E. Schein,Steven E. Schumacher,Yan Shi,Janae V. Simons,Payal Sipahimalani,Tara Skelly,Matthew G. Soloway,Carrie Sougnez,Angela Tam,Donghui Tan,Nina Thiessen,Umadevi Veluvolu,Min Wang,Matthew D. Wilkerson,Tina Wong,Junyuan Wu,Liu Xi,Jane Zhou,Jason Bedford,Fengju Chen,Yao Fu,Mark Gerstein,David Haussler,Katayoon Kasaian,Phillip H. Lai,Shiyun Ling,Amie Radenbaugh,David Van Den Berg,John N. Weinstein,Jingchun Zhu,Monique Albert,Iakovina Alexopoulou,Jeremiah J. Andersen,J. Todd Auman,John Bartlett,Sheldon I. Bastacky,Julie Bergsten,Michael L. Blute,Lori Boice,Roni J. Bollag,Jeff Boyd,Erik P. Castle,Ying-Bei Chen,John C. Cheville,Erin Curley,Benjamin Davies,April DeVolk,Rajiv Dhir,Laura Dike,John Eckman,Jay Engel,Jodi Harr,Ronald L. Hrebinko,Mei Huang,Lori Huelsenbeck-Dill,Mary Iacocca,Bruce L. Jacobs,Michael Lobis,Jodi K. Maranchie,Scott McMeekin,Jerome Myers,Joel Nelson,Jeremy Parfitt,Anil V. Parwani,Nicholas J. Petrelli,Brenda Rabeno,Somak Roy,Andrew Salner,Joel Slaton,Melissa L. Stanton,R. Houston Thompson,Leigh B. Thorne,Kelinda Tucker,Paul M. Weinberger,Cynthia Winemiller,Leigh Anne Zach,Rosemary E. Zuna +227 more
TL;DR: Type 1 and type 2 papillary renal-cell carcinomas were shown to be different types of renal cancer characterized by specific genetic alterations, with type 2 further classified into three individual subgroups on the basis of molecular differences associated with patient survival.
Journal ArticleDOI
Oxidant-induced dopamine polymerization for multifunctional coatings
TL;DR: Polydopamine-coating can be prepared in acidic, neutral and alkaline aqueous media by oxidant-induced polymerization, which is material-independent and multifunctional for surface modification as mentioned in this paper.
Journal ArticleDOI
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells
William J. Israelsen,Talya L. Dayton,Shawn M. Davidson,Brian P. Fiske,Aaron M. Hosios,Gary Bellinger,Jie Li,Yimin Yu,Mika Sasaki,James W. Horner,Laura N. Burga,Jianxin Xie,Michael J. Jurczak,Ronald A. DePinho,Clary B. Clish,Tyler Jacks,Richard G. Kibbey,Gerburg M. Wulf,Dolores Di Vizio,Dolores Di Vizio,Gordon B. Mills,Lewis C. Cantley,Matthew G. Vander Heiden,Matthew G. Vander Heiden +23 more
TL;DR: The pyruvate kinase M2 isoform (PKM2) is expressed in cancer and plays a role in regulating anabolic metabolism as mentioned in this paper, but it is not necessary for tumor cell proliferation and implies that the inactive state of PKM2 is associated with the proliferating cell population within tumors.
Journal ArticleDOI
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W.T. Cheung,Bryan T. Hennessy,Bryan T. Hennessy,Jie Li,Shuangxing Yu,Andrea P. Myers,Bojana Djordjevic,Yiling Lu,Katherine Stemke-Hale,Mary D. Dyer,Fan Zhang,Zhenlin Ju,Lewis C. Cantley,Steven E. Scherer,Han Liang,Karen H. Lu,Russell Broaddus,Gordon B. Mills +17 more
TL;DR: It is demonstrated that phosphatidylinositol 3-kinase (PI3K) pathway aberrations occur in >80% of endometrioid endometrial cancers, with coordinate mutations of multiple PI3K pathway members being more common than predicted by chance.
Journal ArticleDOI
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
Leng Han,Lixia Diao,Shuangxing Yu,Xiaoyan Xu,Xiaoyan Xu,Jie Li,Rui Zhang,Yang Yang,Yang Yang,Henrica M.J. Werner,Henrica M.J. Werner,A. Karina Eterovic,Yuan Yuan,Jun Li,Nikitha Nair,Rosalba Minelli,Yiu Huen Tsang,Lydia W.T. Cheung,Kang Jin Jeong,Jason Roszik,Zhenlin Ju,Scott E. Woodman,Yiling Lu,Kenneth L. Scott,Jin Billy Li,Gordon B. Mills,Han Liang +26 more
TL;DR: The effects of several cross-tumor nonsynonymous RNA editing events on cell viability are experimentally demonstrated and the evidence that RNA editing could selectively affect drug sensitivity is provided, highlighting RNA editing as an exciting theme for investigating cancer mechanisms, biomarkers, and treatments.